The invention relates to novel pyrrolidine derivatives of formula (I):
wherein R
1
, R
2
and R
3
are as defined herein, as inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5). QC catalyzes the intramolecular cyclization of N-terminal glutamine residues into pyroglutamic acid (5-oxo-prolyl, pGlu*) under liberation of ammonia and the intramolecular cyclization of N-terminal glutamate residues into pyroglutamic acid under liberation of water.
ABSTRACT We have developed improved general simple methods for large-scale preparation of polyalkylated imidazoles by improved multicomponent synthesis from commercially available starting materials. A large range of NH- and N-alkyl-polyalkylimidazoles (40 in total, including novel compounds) has been synthesized. GRAPHICAL ABSTRACT
Compounds of general formula (I):
wherein R
1
, R
2
, R
3
, R
4
, X and Y are as defined herein are inhibitors of glutaminyl cyclase and are therefore useful in treating conditions that can be treated by modulation of glutaminyl cyclase activity.
[EN] IONIC COMPOSITIONS AND RELATED USES THEREOF<br/>[FR] COMPOSITIONS IONIQUES ET LEURS UTILISATIONS ASSOCIÉES
申请人:NITTO DENKO CORP
公开号:WO2018161025A1
公开(公告)日:2018-09-07
The present disclosure generally relates to ionic compositions which may be used in or as an adhesive material for selectively adhering two items together. More particularly, but not exclusively, the present disclosure relates to ionic compositions that include a cationic imidazolium compound and an anionic compound such as a sulfonyl imide compound.